Market Pulse
Connect Biopharma stock up more than 40% after trial data
3/17/23 4:38 PM ET (MarketWatch)Print
Connect Biopharma Holdings Ltd. (CNTB) stock rose more than 40% in the extended session Friday after the company said that analysis of a trial involving one of its therapies to treat moderate-to-severe atopic dermatitis showed "rapid and sustained improvement" in signs and symptoms of the illness as compared to a placebo. The stock had ended the regular trading day down 3.5%.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 17, 2023 16:38 ET (20:38 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
, 
, 
Copyright ©2023. All rights reserved.